These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28698954)

  • 21. First-trimester screening: an overview.
    Eiben B; Glaubitz R
    J Histochem Cytochem; 2005 Mar; 53(3):281-3. PubMed ID: 15750002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First and second trimester screening for fetal structural anomalies.
    Edwards L; Hui L
    Semin Fetal Neonatal Med; 2018 Apr; 23(2):102-111. PubMed ID: 29233624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First trimester contingent testing with either nuchal translucency or cell-free DNA. Cost efficiency and the role of ultrasound dating.
    Conner P; Gustafsson S; Kublickas M
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):368-75. PubMed ID: 25581307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice.
    Stenhouse EJ; Crossley JA; Aitken DA; Brogan K; Cameron AD; Connor JM
    Prenat Diagn; 2004 Oct; 24(10):774-80. PubMed ID: 15503268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era.
    Kenkhuis MJA; Bakker M; Bardi F; Fontanella F; Bakker MK; Fleurke-Rozema JH; Bilardo CM
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):463-469. PubMed ID: 28397377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obstetric outcomes in pregnancies with normal nuchal translucency and abnormal ductus venosus Doppler in the first trimester ultrasonography.
    Seckin KD; Karslı MF; Baser E; Yeral MI; Tasin C; Ozgu Erdinc AS; Danisman N
    J Obstet Gynaecol; 2016 May; 36(4):440-3. PubMed ID: 26457755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies.
    Miguelez J; De Lourdes Brizot M; Liao AW; De Carvalho MH; Zugaib M
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):274-8. PubMed ID: 21484908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective assessment of the Hong Kong Hospital Authority universal Down syndrome screening programme.
    Sahota DS; Leung WC; Chan WP; To WW; Lau ET; Leung TY
    Hong Kong Med J; 2013 Apr; 19(2):101-8. PubMed ID: 23535668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Screening for chromosomal abnormalities using nuchal translucency measurement with materal serum biochemistry markers in first trimester].
    Liao SX; Huang FF; Yang YL; Song ZB; Wang YT; Wang ZC; Qu XZ; Chen HP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 37(1):39-41. PubMed ID: 15719038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can increased nuchal translucency in the first trimester of pregnancy predict gestational diabetes mellitus.
    Kelekci S; Yilmaz B; Savan K; Sonmez S
    J Obstet Gynaecol; 2005 Aug; 25(6):579-82. PubMed ID: 16234144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
    Josefsson A; Molander E; Selbing A
    Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21.
    Sahota DS; Leung TY; Fung TY; Chan LW; Law LW; Lau TK
    Ultrasound Obstet Gynecol; 2009 Apr; 33(4):387-93. PubMed ID: 19306471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down syndrome screening in the first and second trimesters: what do the data show?
    Rosen T; D'Alton ME
    Semin Perinatol; 2005 Dec; 29(6):367-75. PubMed ID: 16533649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Book: Genetics for obstetricians and gynaecologists: Chapter: Genetic markers on ultrasound scan.
    Sivanathan J; Thilaganathan B
    Best Pract Res Clin Obstet Gynaecol; 2017 Jul; 42():64-85. PubMed ID: 28456373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for adverse pregnancy outcome at early gestational age.
    Hourrier S; Salomon LJ; Dreux S; Muller F
    Clin Chim Acta; 2010 Nov; 411(21-22):1547-52. PubMed ID: 20599860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First trimester risk assessment for trisomy 21 in twin pregnancies combining nuchal translucency and first trimester biochemical markers.
    Prats P; Rodríguez I; Comas C; Puerto B
    Prenat Diagn; 2012 Oct; 32(10):927-32. PubMed ID: 22752980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [What are the real purpose and scope of screening for aneuploidy?].
    Quibel T; Rozenberg P
    Gynecol Obstet Fertil Senol; 2018 Feb; 46(2):124-129. PubMed ID: 29396076
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.